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Abstract
 
Receptor editing is performed by replacement of V
 
  
 
genes that contribute to autoreactivity. In
addition, the C
 
  
 
locus can be deleted by V
 
  
 
rearrangement to intronic or 3
 
  
 
of C
 
  
 
RS sequences
(also referred to as 
 
  
 
deletion elements). B cells that delete the C
 
  
 
can then express 
 
  
 
light
chains. However, the 
 
  
 
locus, either of man or mouse, does not allow V gene replacement.
Nor does it appear to be deleted. Therefore, editing of autoreactive 
 
  
 
B cells may require alter-
native pathways. We have found that in anti-DNA heavy chain transgenic mice (tgs) V
 
H
 
3H9/
56R, B cells that express anti-DNA receptors comprised of 
 
 
 
1 in association with an anti-DNA
heavy chain often coexpress a 
 
  
 
chain that prevents DNA binding. We speculate that such iso-
typically included cells may have low anti-DNA receptor densities, a feature that may lead to
self-tolerance. Here we describe a mechanism of preventing DNA binding by expression of a
rarely used member of the V
 
  
 
family, V
 
 
 
x. The 
 
 
 
x B cells of the tgs also express CD25 and
may represent B cells that have exhausted light chain editing possibilities.
Key words: autoimmunity • lupus • CD25 • light chain • myelin basic protein
 
Introduction
 
Self-reactive B cells are rendered tolerant by several mech-
anisms including inactivation, receptor editing, and deletion.
In addition, interaction with self-antigen may impede exit
from the bone marrow, in which case the B cells may die
in situ. Which mechanism(s) is used depends on the state of
self-antigen (i.e., soluble vs. membrane-bound) and on the
avidity for a self-antigen (1–6). Anti-DNA transgenic mice
(tgs) are important because the transgene-encoded antibody
is directed against a constitutive self-antigen, DNA, the
major target of autoantibodies in SLE (7). The 3H9 anti-DNA
model is especially relevant because the genes coding for
3H9 anti-DNA were derived from a diseased MRL/lpr
mouse and the 3H9 antibody is typical of the pathogenic
anti-DNAs in SLE (8). Understanding how this autoantibody
is controlled in healthy mice is important for understanding
why self-tolerance fails in SLE.
The 3H9 anti-DNA has unique and useful properties.
Although most antibodies bind antigen through a combi-
nation of V
 
H 
 
and V
 
L 
 
residues (9), DNA binding by 3H9 is
mediated mainly by arginine residues in V
 
H 
 
(10). Hence,
the H chain tgs by themselves are informative because they
can be studied in the context of the endogenous L chain
repertoire. The H chain–only tgs show that the majority of
V
 
L
 
s have no influence on binding but some V
 
L
 
s (editors)
can modify or inhibit the V
 
H
 
–DNA interaction (11).
Healthy 3H9 H chain tgs express the 3H9 H chain, but
only in combination with V
 
L 
 
editors (5, 6).
The range and efficiency of editing is influenced by the
antigen-binding characteristics of the antibody: anti-ssDNA
(represented by the 3H9/V
 
 
 
8 combination) are inactivated
(4), whereas anti-dsDNA and anti-phosphatidylserine are
edited (5, 6, 12). Anti-DNAs, such as 3H9, are useful in
this regard because the stringency of DNA binding can be
modified simply by adding or subtracting arginine residues
(10). Thereby we can extend our study to transgenes with a
range of affinities for DNA. Studies on anti-DNAs tgs derived
from such modified H chains show that the tolerance is
mainly achieved by receptor editing. Although editing is an
efficient mechanism, it can result in allelic and isotypic (
 
 
 
and 
 
 
 
) inclusion. We have observed increased inclusion in
V
 
H
 
3H9 and V
 
H
 
3H9/56R tgs (5, 13). Typically, allelically
and isotypically included B cells coexpress an L chain that
permits DNA binding and an L chain editor.
Another effect of receptor editing is to bias the repertoire
of V genes toward those that rearrange late or rarely in the
sequence of rearrangement. We have discovered a population
of B cells in the V
 
H
 
3H9/56R transgenic mouse (tg) that is
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extremely biased toward V
 
 
 
x-J
 
 
 
2. This L chain is an editor
as it has a low isoelectric point (IEP) and, when combined
with 3H9/56R, the combination does not bind DNA (14).
Because 
 
  
 
genes are thought to rearrange after 
 
  
 
genes (15,
16), this population is another example of the influence of
editing on V gene repertoire. This population is unusual
because it bears the activation marker, CD25, and we dis-
cuss the possible origin of this population.
 
Materials and Methods
 
Mice.
 
Site-directed V
 
H
 
3H9/56R H chain tgs on BALB/c or
CB17 background have been described (17). The tgs were
crossed to the immunoglobulin 
 
 
 
-deficient (J
 
 
 
del) mice (18). All
mice used in the experiments were between 6–8 wk old.
 
Genotyping of the tgs.
 
The PCR for typing the V
 
H
 
3H9/56R
tgs has been described (17). For typing the J
 
 
 
del mice, two sepa-
rate PCR assays were performed with the following primer pairs:
to detect the targeted inactivation of the 
 
  
 
gene by J
 
 
 
C
 
  
 
deletion
(18), the forward primer 5
 
 
 
-AAGAGCTTGGCGGCGAATGG-
3
 
  
 
corresponding to the inserted neo gene and the reverse primer
5
 
 
 
-CAAACCTACCATGGCCAGAGA-3
 
  
 
corresponding to the
remaining 3
 
  
 
region of the 
 
  
 
locus were used. The wild-type 
 
 
 
locus (
 
 
 
 
 
) was detected by the forward primer 5
 
 
 
-CTGTAAAT-
CACATTCAGTGATGG-3
 
  
 
corresponding to J
 
 
 
3 and the re-
verse primer 5
 
 
 
-CCGAGCCGAACGTGAATCACA-3
 
  
 
corre-
sponding to J
 
 
 
4. Both PCRs were performed with a final
concentration of 250 
 
 
 
M of each dNTP and 2 mM MgCl
 
2 
 
at
60
 
 
 
C annealing temperature.
 
Flow Cytometry.
 
The following antibodies were used for flow
cytometry: FITC-conjugated polyclonal goat anti–mouse 
 
 
 
(Fisher Scientific), biotin-conjugated anti-
 
  
 
(R26-46), PE-con-
jugated anti-CD25 (3C7), APC-conjugated anti-B220 (RA3-
6B2), FITC-conjugated anti-IgD
 
a 
 
(AMS9.1), biotin or PE-con-
jugated anti-IgD
 
b 
 
(217-170; BD Biosciences), FITC-conjugated
anti-IgD (11-26), and biotin-conjugated goat anti–IgM (South-
ern Biotechnology Associates, Inc.). Stained cells were analyzed
using a FACScan™ flow cytometer and CELLQuest™ software
(Becton Dickinson).
 
Cell Sorting.
 
Splenic B cells from V
 
H
 
3H9/56R tgs were
stained with FITC-conjugated anti-CD19 (1D3) and PE-conju-
gated anti-CD25 (3C7; BD Biosciences). Dead cells were ex-
cluded by propidium iodide staining. The CD25
 
 
 
/CD19
 
  
 
and
the CD25
 
 
 
/CD19
 
  
 
fractions were sorted using a FACS Van-
tage™ flow cytometer (Becton Dickinson).
 
PCR.
 
Total RNA was prepared from sorted B cells with
RNeasy Mini Kit (QIAGEN). RT was performed using First-
Strand cDNA Synthesis Kit (Amersham Biosciences). In addition,
genomic DNA from sorted cells was purified using the previously
described protocol (19). PCR-detecting V
 
 
 
x rearrangement was
performed as previously described (19). The PCR products were
cloned into pGEM
 
®
 
-T easy vector (Promega). Approximately
seven to eight clones of each PCR were randomly picked and se-
quenced with the T7 primer. C
 
  
 
deletion was detected using Vs
as a forward primer and RS-101 as a reverse primer as previously
described (20). The control actin PCR was performed using the
forward primer 5
 
 
 
-GGTGTCATGGTAGGTATGGGT-3
 
  
 
and
the reverse primer 5
 
 
 
-GATGTCGCGCACAATCTCACGT-
TCAG-3
 
  
 
(21).
 
Single Cell PCR.
 
Spleen B cells were enriched by purifica-
tion with anti-B220 magnetic beads (Miltenyi Biotec). The cells
were then stained with anti-CD19 FITC and anti-CD25 PE and
sorted into 96-well plates. cDNA was synthesized according to
the previously described protocol (22) and was used in two types
of PCR-detecting V
 
 
 
x-J
 
 
 
2 and V
 
H
 
3H9/56R transcripts. Each
type of PCR has two rounds of reactions (40 
 
 
 
l reactions with 10
pmol of each primer, 1.56 mM MgCl
 
2
 
, and 0.2 
 
 
 
l AmpliTag
Gold). 50 cycles of PCR were performed at 94
 
 
 
C for 20 s, 55
 
 
 
C
for 40 s, and 72
 
 
 
C for 1 min. The following primers were used
for V
 
 
 
x-J
 
 
 
2: first round ACCTTGAGTAGTCAGCACAG and
CTAGGACAGTGACCTTGGTT; second round GAGCTTA-
AGAAAGATGGAAGCCA and GTTCCACCGCCGAAAAC-
ATA. The following primers were used for V
 
H
 
3H9/56R: first
round CAGGTTCAACTGCAGCAGTC and GGGATCCTG-
GGAAGGACTGACTCTC (C
 
 
 
; reference 23); second round
AGTAGCTCCTGGATGAACTGG and CATAACATAGGA-
ATATTTACTCCTCGC.
 
Generation of Rabbit Anti–V
 
 
 
x Antibody.
 
A peptide corre-
sponding to a sequence spanning the FWR2 and CDR2 region
of V
 
 
 
x (N
 
 
 
-CPPKYVMELKKDGSHSTGD-C
 
 
 
), which has no
homology to V
 
 
 
1 or V
 
 
 
2, was synthesized. The amino-terminal
cysteine was added for conjugation. The peptide was conjugated
to maleimide-activated mariculture keyhole limpet hemocyanin
(Pierce Chemical Co.). 0.5 mg immunogen in PBS was mixed
with Freund’s adjuvant (GIBCO BRL) and injected into a rabbit.
The animal was boosted every 28 d with 0.2 mg immunogen
mixed with Freund’s adjuvant (GIBCO BRL). Blood was col-
lected 14 d after each injection. IgG was precipitated from the se-
rum using Na
 
2
 
SO
 
4 
 
at a final concentration of 0.18 g/ml of serum.
The precipitates were dissolved in 17.5 mM sodium phosphate
buffer. Anti-V
 
 
 
x antibody was purified using an affinity column
of the synthetic peptide conjugated to SulfoLink Coupling Gel
(Pierce Chemical Co.).
 
Magnetic Sorting and Western Blot.
 
CD25
 
  
 
B cells were en-
riched magnetically after staining with PE-conjugated anti-CD25
(3C7) followed by attachment to anti-PE magnetic beads (Mil-
tenyi Biotec). The CD25
 
  
 
B cells from the same mice (flow
through of anti-CD25 purification) and B cells from nontransgenic
BALB/c mice were purified with anti-B220 magnetic beads
(Miltenyi Biotec). Cells were lysed on ice for 30 min in buffer
containing 1% Triton X-100, 50 mM Tris, pH 7.6, 150 mM
NaCl, and 1 mM AEBSF (Sigma-Aldrich). The lysate was soni-
cated and centrifuged for 20 min at 12,000 
 
g
 
. Supernatant was
mixed with SDS sample buffer and boiled for 5 min. Proteins were
resolved on a 10% SDS PAGE under reducing conditions and
transferred to PVDF membrane (Bio-Rad Laboratories) at 200 mV
for 2 h. After blocking with 5% nonfat milk in PBS, the blot was
probed for 1 h at room temperature with rabbit anti–V
 
 
 
x. The
membrane was washed three times for 5 min with PBS containing
0.05% Tween 20, incubated with horseradish peroxidase–conju-
gated goat anti–rabbit IgG (Bio-Rad Laboratories), and developed
using SuperSignal West Pico Kit (Pierce Chemical Co.).
 
Computation of 
 
  
 
and 
 
  
 
Expression Frequency.
 
The frequency
of 
 
  and   L chain expression was computed using a Monte Carlo
computer simulation. The simulation design and mathematical de-
tails have been described (24) and are at http://www.cs.biu.ac.il/
~louzouy/simulations/kl.htm. We describe hereby the details rel-
evant to the current analysis. The simulation contains one   locus
(with each allele rearranging separately) and two   loci ( 1 and
 2/ x). Rearrangement is assumed to occur simultaneously and
independently on each allele. Rearrangement is modeled as a sto-
chastic process. Rearrangement was determined by the probability
of rearrangement initiation (0.1 per cycle) and by the length of the
rearrangement process. The low initiation probability reduces the
number of cells presenting two different functional   alleles and isLi et al. 339
consistent with Schlissel’s (25) estimate.   allelic exclusion is thus
practically guarantied by the low initiation probability.  /  iso-
typic exclusion is guarantied by the longer rearrangement process
in   (50 cycles) than in   (5 cycles).
At the   locus rearrangement is between any V  and a J . J  is
chosen according to a quasi-sequential model (unpublished data).
In the  1 locus rearrangement is between V 1 and J 1 (i.e., we
ignore the possible rearrangement to  3). At the  2/ x locus, we
assumed that half the rearrangements are V 2 to J 2 and half are
V x to J 2 (26).
Further rearrangements are required if the resulting L chain is
either out of frame or anti-self. We assumed that 33% of all rear-
rangements are in frame and that in the non-tg self-antigen bind-
ing is rare (and thus in this simulation neglected). In the VH3H9/
56R tg, we assumed that all V s except for V 21D, V 20, and
V 38c (editors) combined with any J  gene and all V s except for
V x are anti-self. Note that rearrangement on all alleles was as-
sumed to be simultaneous, thus multiple functional L chains can
be produced. If the L chain does not bind self-antigen, a nonself L
chain double expresser can be produced. If one of the L chains
binds self-antigen (in the context of the given H chain) and the
other one does not, we assumed that the cell would mature only if
the majority of L chains are from the nonself type (24). An exam-
ple of a partially self-reactive double expresser cell would be the
combination of a V  editor combined with a V 1 rearrangement.
If rearrangement is either anti-self or nonfunctional on all L
chain loci, rearrangement continues until either all  s and  s are
rearranged or the cell dies. Cell death is introduced using a crash
factor added to the Langman and Cohn concept (27) to explain
the observed   to   usage ratio (15–20:1) in non-tg (see Discus-
sion). Note that   rearrangement cannot be deleted. Thus, an
anti-self   rearrangement must lead either to cell death or to par-
tially self-reactive double expresser.
Results
VH3H9/56R tgs Have a Population of CD25  Spleen B
Cells That Express the  x L Chain. In our studies on site-
directed anti-DNA H chain tgs, we found that the
VH3H9/56R BALB/c tg has an unusual set of spleen B
cells that express the activation marker CD25. CD25 is the
IL-2 receptor   chain and is reported to be expressed on
both pre–B cells and activated B cells (28, 29). The CD25 
B cells represent 13.2% (SD 2.2, n   7) of the B220  B cell
population of VH3H9/56R, but these B cells are not de-
tectable in either the nontransgenic littermates of this tg
(Fig. 1 A) or tgs with anti-DNA H chain transgenes such as
3H9 and 3H9/56R/76R (unpublished data).
Like normal mature follicular B cells, these CD25  B
cells are IgM  and IgD . Yet they attracted our attention
because no L chain expression could be detected by the
commercially available anti-  or anti-  antibodies (Fig. 1
B). However, the frequency of these CD25  B cells is
higher in VH3H9/56R  -deficient mice, suggesting that
these B cells do express   chain. The CD25  population
size is inversely proportional to the number of   alleles.
Deletion of one   allele increases the percentage to 18.1
(SD 3.6, n   4) and 55.0% (SD 18.1, n   4) when both  s
are deleted (Fig. 2). The most likely   chain is the V x. Al-
though this V  is located in the J 2-C 2 locus and is usu-
ally rearranged to J 2, its V region is only 33% identical to
the V 2 (Identity to V 1 and mouse V s is also  35% but
homology to human V 5-6 and V 5-1 is high, at 75 and
70%, respectively.). If anti-  antibodies are directed to the
V region, then V x/C 2 may not be recognized by these
reagents. Indeed, molecular analysis of L chain rearrange-
ment (see below) shows that V x is rearranged in the
CD25  population.
V x is barely detectable in normal mouse serum but
reaches significant levels in  -deficient mice (26, 30). V x
has also been found in the hybridoma panel generated from
the tgs that express the 3H9/56R H chain (14). As shown
in Fig. 2, we find that  21% of B220  B cells of nontrans-
genic J del/J del mice have no L chain according to either
the anti-  or anti-  antibodies discussed above. We pre-
sume that they express V x. In the nontransgenic  -defi-
cient mouse, the   /   (putative   x population) is not
CD25 , whereas most or all of the comparable population
is CD25  in the tg (Fig. 2). Hence, 3H9/56R/ x B cells
per se express the activation marker. Other activation
markers such as CD69 or elevated Fas are not found on
Figure 1. CD25 /IgM /IgD  spleen B cells of VH3H9/56R mice.
(A) Spleen cells from VH3H9/56R BALB/c mice and its nontransgenic
littermate were stained with anti-B220 and CD25. Percentages of
CD25 /B220  cells in a lymphoid gate are indicated. (B) Spleen cells
from VH3H9/56R BALB/c mice were stained with  ,  , IgM, and IgD.
Results of IgM/IgD and  /  staining are shown for the whole lymphocyte
gate (left) and the B220 / CD25  gate (right).Editing Anti-DNA B Cells by V x 340
these cells. Nor do they express CD11c or CD103, markers
that are expressed by hairy cells, the CD25  clonally ex-
panded mature activated B cells (31 and unpublished data).
Molecular Analysis of V x. To confirm that conven-
tional L chains are replaced by V x, we sorted the CD25 
cells from the spleen of VH3H9/56R tg and performed a
V x RT-PCR. We used a J 2 primer and a V x primer
corresponding to a sequence spanning the FW2 and CDR2
region, which has no homology to V 1, V 2, or V . A
stronger signal is detected in the CD25  fraction than the
CD25  B cells sorted from the same mice (Fig. 3). PCR
using genomic DNA from sorted cells shows similar results
(see Fig. 6, middle).
To detect the expression of V x at protein level, a poly-
clonal antibody was generated by immunizing a rabbit with
a peptide corresponding to a sequence spanning the FWR2
and CDR2 region of V x, which has no homology to V 1
or V 2. Western blot using cell lysate of  x,  1, and   hy-
bridomas demonstrates that the antibody recognizes a single
band with the molecular weight of 27 kD from the lysates
of  x hybridomas and does not cross talk with  1 or   L
chains (Fig. 4 A). The observed molecular weight of  x is
about the same as that which has been reported by another
group using their antibody (32). We then did the Western
blot using cell lysates from purified CD25   B cells,
CD25 /B220  B cells from the tg, and B220  B cells from
non-tg BALB/c mice. The CD25  cells shows a strong
band of  x. The CD25 /B220  cells sorted from the same
mice show a much weaker band and B220  cells from non-
Figure 2. Deletion of   L chain loci increases the frequency of CD25  B cells that express V x. Spleen cells from VH3H9/56R and   L chain–deficient
mice (J del/  , J /C  deletion on one   allele; J del/J del, deletion on both alleles) with or without the 3H9/56R transgene were stained with anti-B220,
CD25,  ,  , IgM, and IgD. The percentages of the CD25 /B220  cells in the B220  B cells are indicated in the top. On the middle and bottom panels
are the  /  staining of cells in the CD25 /B220  and the B220  gates, respectively.
Figure 3. CD25  B cells express the V x-J 2 mRNA. CD25 /CD19 
and the CD25 /CD19  B cells were isolated from the spleens of VH3H9/
56R mice using anti-CD19 and CD25 antibodies and a FACS Vantage™
flow cytometer. cDNAs were synthesized from total RNA extracted from
both fractions. V x-J 2 PRC was performed on serial dilutes of cDNA
from each sample. The bottom panel shows the actin PCR.Li et al. 341
transgenic BALB/c mice show no signal (Fig. 4 B). We
were not able to use the antibody to perform flow cytome-
try as it only recognizes the denatured  x protein.
The CD25  B Cells Express the Transgene Allele. The
CD25 / x population appears to depend on the presence
of the 3H9/56R transgene. As discussed above,  x B cells
in non-tgs are CD25 . However, hybridoma panels from
this tg show that 17% of the hybridomas have undergone
replacement of the transgene VH (17). Therefore, it was im-
portant to confirm that the CD25  B cells coexpress  x and
the 3H9/56R H chain. We tested transgene expression by
allotype analysis. The Iga tgs were crossed to CB17 mice
(Igb) and the B cells from the allotype heterozygous mice
were stained with allotype-specific antibodies. Nearly all of
the CD25  B cells express the transgene allotype (Fig. 5).
This, however, does not rule out the possibility that the
transgene VH is replaced and that the Iga C region is retained
(33). To address this, we tested the expression of the 3H9/
56R H chain together with V x by single cell PCR. 22 of
48 (45.8%) CD25  cells are positive for the V x-J 2 PCR,
whereas only 4 of 48 (8.3%) CD25  cells sorted from the
same mice are positive. 12 of the 22 CD25 / x cells
(54.5%) are positive for the PCR detecting the 3H9/56R H
chain. We do not know if this is the actual percentage of
transgene  cells because the efficiency of the assay has not
been determined. However, this result shows that at least
50% of the cells in this population retain the transgene.
The CD25  B Cells Show Extensive Rearrangement at the  
L Chain Loci. The apparent order of L chain rearrange-
ment is   and then  . Consequently,   B cells usually have
not rearranged   loci, and   B cells have rearranged and/or
deleted   alleles (15, 16). Therefore, we would expect the
CD25 / x population to have extensive   rearrangement.
To test this prediction, we performed a PCR on genomic
DNA from sorted CD25  B cells using primers that detect
C  deletion. A stronger signal was detected in the CD25 
fraction than in the CD25  fraction (Fig. 6). This implies that
these  x B cells failed to rearrange a functional   or rearrange
a   with the ability to prevent, i.e., edit, the DNA-binding
capacity of the 3H9/56R H chain. It should be noted that
 x, but not V 1 or V 2, is an editor of 3H9/56R.
V x Can Rearrange to Different J s. V 1 and V 2 can
and do rearrange to different J s (Fig. 7 A, J 1, J 2, or J 3;
reference 26). Alternate J  usage of V x has not been de-
scribed. Whether rearrangement to other J s occur in the
tgs was tested by sequence analysis. RT-PCR was per-
formed using cDNA from sorted CD25  cells together
with the upstream V x primer and the downstream J 1 or
J 2,3 primers. PCR products of both V x-J 1 and V x-
J 2,3 were cloned and sequenced at random. Eight se-
quences of V x-J 2 rearrangements were in frame and
have the same junction but only two of the seven V x-J 1
rearrangement were in frame (no V x-J 3 rearrangements
were found). These V x-J 1 junctions have interesting
features including possible N addition and large deletions
(Fig. 7 B). V -J  sequences usually do not exhibit this sort
of diversity but SCID mice do have deletions at   junctions
(34). Thus, these B cells may have atypical TdT and DNA-
PK expression.
Computation of L Chain Isotype Expression Frequency.
The computer simulation of   and   rearrangement was
used to compare the expected and observed repertoire of
VH3H9/56R tgs and non-tgs. The results presented in Ta-
ble I show the expected repertoire, if rearrangement had
been responsible for all differences between the non-tgs
and VH3H9/56R tgs. The differences between the simula-
tion and the observed results probably represents elements
that are not strictly due to the mechanism of rearrange-
ment, such as positive and negative selection by antigen
(other than negative selection by DNA, which is already
taken into account in our analysis) or differential longevity
in the various compartments of the immune system.
We further analyzed the effect of deleting   alleles. We
modeled the repertoire with both   allele (  /  ), a single
  allele ( del/  ), and no   alleles ( del/ del). The first
row represents the total   populations, and the second row
represents the   ( 1 and  2, not including  x) population.
The regular non-tg has a 15:1  /  ratio as is indeed ob-
served. This ratio is the result of the introduction of the
crash factor model introduced by Coleclough et al. (16). A
high crash factor increases the probability that cells should
Figure 4. Western blot analysis of  x. (A) Verifying the specificity of
anti-V x antibody. Cell lysates of three different  x hybridomas (lanes 1–3;
chosen because they are positive for V x-J 2 by PCR but negative in
both   and   ELISA), a  1 (lane 4), and a   hybridoma (lane 5) were used
for the analysis. (B) Detection of  x protein expression in CD25  cells.
Cell lysates of purified CD25  and CD25 /B220  B cells from the tg and
B220  B cells from non-tg BALB/c mice were used for the Western blot.
The positive control (lane 1) is the supernatant collected from a  x hybrid-
oma. The lower 23-kD band is most likely a degradation fragment of  x.Editing Anti-DNA B Cells by V x 342
die before they manage to rearrange the   allele, and thus
decreases the   usage frequency. The  /  ratio is lower in
the mice with a single   allele than in mice with both   al-
leles. This decrease is explained by the reduced probability
of the obtainment of a functional   ( 50% with one allele
compared with 75% with two alleles. We assume that each
rearrangement has a 33% chance of being in frame and a 43
out of 140 chance of being a pseudo gene.). We computed
the average number of rearrangement in the presence of
the crash factor and the J order. In the absence of   alleles,
all L chains are obviously V 1, V 2, or V x. In the
VH3H9/56R tg, both V 1 and V 2 bind DNA in con-
junction with the H chain transgene. Thus, if negative se-
lection is 100% efficient, no pure   B cell can mature and
the  /  ratio is infinity. Note that not all cells will carry a  
L chain because the V x is an editor and will therefore not
be negatively selected.
The third row represents the frequency of V x. The
V x frequency in non-tg is lower than that of V 1 (19,
35). In the absence of selection, we expect the frequency of
V x to be 50% that of V 1 because there is only one rear-
rangement possibility in the  1 locus, and there are two
such possibilities in the  2/ x locus. Thus, we expect the
ratio of V (1 2)/V x to be 3:1 (Table I). A completely
Figure 5. The CD25  B cells from VH3H9/56R express the transgene allele (Iga). Spleen cells from BALB/c (Iga), CB17 (Igb), and CB17 mice carrying
the 3H9/56R transgene (Iga) were stained with antibodies to B220, CD25, IgDa, and IgDb. The top panel shows the frequency of CD25  B220  from
the VH3H9/56R CB17. BALB/c or CB17 mice have background levels of these cells. The bottom panel (left to right) shows the IgDa/IgDb staining
of the B220  cells from BALB/c, CB17, VH3H9/56R CB17, and CD25  B220  cells of the VH3H9/56R CB17.
Figure 6. The CD25  B cells in VH3H9/56R tgs
have gone through extensive rearrangement at the   L
chain loci. Genomic DNA was prepared from CD25 
CD19  and CD25  CD19  B cells sorted from the
spleen of VH3H9/56 tgs. PCRs that detect C  deletion
(top, Vs-RS101) and V x-J 2 rearrangement (middle),
and the control actin PCR (bottom) were performed
using serial dilutions of DNA from each sample.Li et al. 343
different picture emerges in the VH3H9/56R tg. In this
mouse V x is an editor, whereas V 1 and V 2 are not.
Therefore, the L chain should be (unless allelically in-
cluded) V x. Moreover, the frequency of V x is greater
than any V  editor (2 vs. 0.66%). Because there are only
three   editors, we expect roughly the same amount of  
and V x L chain expressers in the VH3H9/56R tg, as is ob-
served in our simulation.
Rows four to seven in Table I represent the frequency of
included cells. The observed  /  inclusion frequency is
 2% as in the study by Casellas et al. (36). The level of  
inclusion is lower in the VH3H9/56R tg because the prob-
ability of producing a functional nonself   is lower than
non-tg.  /  inclusion is also very rare in non-tg and its
level in the VH3H9/56R tg is lower or of the same magni-
tude as the non-tg. Rearrangement by itself cannot explain
the high level of  /  inclusion observed in the VH3H9/
56R tg. The low inclusion frequency is due to the fact that
most of the time the   allele is rearranged to extinction be-
fore the   allele starts rearrangement. The probability of in-
clusion is further decreased in the VH3H9/56R tg because
the V 1 is self-reactive, and the only way for a  /  in-
cluded cell to mature is if the V  is an editor, itself a rare
event. A much higher level of inclusion is expected in the
VH3H9/56R tg between V 1 and V x (Table I, row 7).
This inclusion is expected because the cell cannot remove
the anti-self V 1 by editing. The only way for this cell to
survive might be by diluting the V 1 allele with V x.
Thus, the V 1/V x inclusion frequency is high and it is
rising as the total frequency of V x increases. Note that we
never observed in our simulation the theoretically possible
triple inclusion (Table I, row 8).
Discussion
The extent of rearrangement caused by editing depends
on the number of editor L chains encoded in the germ line.
3H9/56R, a mutant of 3H9 H chain with a high affinity
for DNA, has more stringent requirements for editing than
3H9 in that it appears to be edited by fewer V s (3 out of
93 functional V  genes) than 3H9. Therefore, the proba-
bility of rearranging a V  editor for 3H9/56R is low and
alternative ways of achieving self-tolerance such as VH re-
placement are used (17). In addition, B cells that retain the
3H9/56R transgene have a large population of B cells that
express two L chains (13). The L chains that are coex-
pressed include  1, an L chain that permits DNA binding
by the 3H9/56R, and a    editor (V 20, V 21D, and
V 38c). We think this population is resistant to activation
because the coexpression of an anti-DNA receptor and a
Figure 7. Sequences of the V x-
J 2 and V x-J 1 junctions. (A)
Mouse   locus and the primers used
in the experiments. (B) Eight V x-
J 2 and seven V x-J 1 rearrange-
ments were sequenced from randomly
chosen PCR products cloned into
pGEM®-T easy vector. IF, in frame
rearrangement; OF, out-of-frame
rearrangement. In the last two se-
quences of V x-J 1 rearrangement
(bottom), the four nucleotides
CTGG following V x have the
same sequence as the beginning of
germ line J 1 gene. After this se-
quence several nucleotides of J 1 are
missing. Either a deletion occurred
within the rearranged J 1 or these
four nucleotides are N additions and
not the beginning of J 1. The latter
case would mean that there is a 10
nucleotide deletion at the beginning
of the J 1.Editing Anti-DNA B Cells by V x 344
non–anti-DNA receptor dilutes either receptor to the
point that cross-linkage by self-antigen is not efficient. In
addition, the partial self-reactivity of the B cell may confer
special properties to this population, among them the hom-
ing to the marginal zone (13).
As described here, the 3H9/56R tg has a population of
B cells that express the 3H9/56R transgene and the V x-
J 2 L chain. The V x is one of the three functional V
genes of mice, V 1, V 2, and V x. V 1 and V 2 allow
DNA binding by 3H9/56R and related VHs, but V x pro-
hibits DNA binding of 3H9/56R H chain. Thus, these ed-
ited 3H9/56R/ x B cells are not unexpected. V x is only
distantly related to the other V s and among the differences
from V 1 and V 2 is the IEP of its CDR. V x has a very
low IEP (in the range of   editors), whereas the other V s
have IEPs in the upper range of L chain IEP scale. Further-
more, V 1 in combination with 3H9/56R has been shown
to bind DNA (17).
V x has been a neglected V-region for two reasons. One
is its extremely low level of expression in normal mice. In
fact,  x is only detectable in  -deficient mice. A second
reason is that conventional anti-  reagents do not react or
react weakly with V x-J 2. As illustrated here, the B cells
from 3H9/56R include a population that typed   /  
with these anti-  reagents. This population was puzzling
until molecular analysis of members of this population
showed expression of  x L chain.
The V x (and the aforementioned   editor/ 1) B cell
populations, are prominent in the VH3H9/56R tg but are
undetectable in non-tgs or the lower affinity tgs. How
might 3H9/56R produce or influence the size of these
populations?
 /  isotypic exclusion, and for that matter allelic exclu-
sion, are thought to emerge from a series of stochastic
events and rearrangement product alternatives that reduce
the probability of two functional alleles or isotypes. For ex-
ample, the probability of productive rearrangement at   is
low. Furthermore, a rearrangement STOP signal is re-
quired to stabilize a B cell with a functional receptor. The
combination of these factors accounts for the low fre-
quency of allelic inclusion at the   locus (36). Isotype ex-
clusion can be explained by assuming that the probability
of rearrangement of   is greater than  . The relative proba-
bilities of   versus   could be determined by differences in
initiation of expression, transcript abundance, quality of re-
arrangement sequences, etc.   allelic and isotype exclusion,
C 1 or C 2, might be determined in a similar fashion.
The number of   and   B cells must also be influenced
by these mechanisms, but reconciling the predictions of
purely probabilistic models with the observed frequencies
of L chain isotypes and monospecific B cells is problematic.
Mouse antibodies are mainly   (the ratio  /    20), but, as
pointed out by Langman and Cohn (27), the probabilistic
model described above would predict a much lower ratio
( 2). Langman and Cohn (27) derived this value by assum-
ing that   /   B cells are the major source of the   popu-
lation (minus those that fail to rearrange   productively)
and that the frequency of  -deficient B cells is high. The
ratio  /    2, is a pre-receptor editing calculation and
hence overestimates the frequency of failed   loci. But ad-
Table I. The Expected Frequency of Different L Chain Isotypes
VH3H9/56R Nontransgenic
  Genotype                        
1.   0.00 25.83 (NA) 41.47 (NA) 0.00 79.09 (NA) 91.72 (87.0a)
2.   0.00 (NA) 0.00 (NA) 0.00 (NA) 74.49 (89.0b) 15.40 (NA) 6.10 (3.9b)
3.  x 93.49 (55.0) 68.21 (18.1) 53.03 (13.2) 24.55 (12.0b) 5.11 (NA) 1.96 (0.8b)
4.     0.00 0.00 0.63 (NA) 0.00 0.00 1.38 (1.5a)
5.     0.00 0.06 (14.0) 0.10 (23.8c) 0.00 0.14 (NA) 0.10 (2.1c)
6.    x 0.00 (NA) 0.97 (NA) 1.50 (NA) 0.00 (NA) 0.04 (NA) 0.03 (NA)
7.    x 6.51 (NA) 4.94 (NA) 3.90 (NA) 0.97 (NA) 0.22 (NA) 0.08 (NA)
8.      x 0.00 (NA) 0.00 (NA) 0.00 (NA) 0.00 (NA) 0.00 (NA) 0.00 (NA)
A cell is defined as  ,  , or  x if it expresses only  ,  1 or  2, or  x L chains. A cell expressing two different L chains is defined as an “included cell”
and is designated   and  ,   and  x, and   and  x. Note that we define a cell expressing  x on both alleles or   on both alleles as an allelically excluded
cell. The simulation was performed using a crash factor to obtain the observed  /  ratio in non-tg. We have performed the simulation with no  
alleles (J del/J del, first and fourth columns), a single   allele (J del/  , second and fifth column), and both   alleles (  /  , third and sixth
columns). The only difference between the non-tg and the VH3H9/56R tg in the simulation is the probability that an L chain will sustain DNA
binding. In the non-tg no DNA binding was assumed. In the VH3H9/56R tg, we assumed all L chains lead to DNA binding except for the editors
V 21D, V 20, V 38c, and V x. All the data obtained by simulation are listed and the observed values are shown in parentheses.
aReference 36.
bReference 38.
cReference 13.
NA, data not available.Li et al. 345
justing the  -deficient population to account for   rescue
by editing still yields a ratio ( 4) far lower than observed.
Coleclough et al. (16) solved this paradox by introducing
the crash factor, which in effect limits rearrangement op-
portunities (a reasonable parameter given the finite lifespan
of a B cell). This limit reduces the number of   /   B cells
that can be produced and in turn reduces the number of B
cells that make the transition to   and, hence, increases the
 /  ratio.
We wish to explain the   contribution to the B cells of
VH3H9/56R tg in the context of the Coleclough et al. (16)
modification of the Langman and Cohn (27) model. We
explained the  /  population of VH3H9/56R by postulat-
ing a significant overlap between   and   rearrangement.
We thought this overlap was the result of extended periods
of   rearrangement in this tg (24) but simulations that in-
clude this factor preclude this explanation (Table I). Our
explanation for the  x population was because of a shift to-
ward late-stage rearrangement driven by receptor editing.
This explains in part the existence of the  x B cells but not
their overall frequency (Table I).
The simulation gives surprising (to us) results with regard
to the frequencies of  /  doubles and  x. The frequency of
 /  doubles does not change in the VH3H9/56R (both
non-tg and VH3H9/56R   0.1%). In the simulation, we as-
sumed that there are three   editors and one  x editor. The
reason for a low  /  frequency in non-tg is the high proba-
bility of deleting the   locus before   even has the opportu-
nity of rearranging. This probability is greatly increased in
VH3H9/56R. As expected, the simulation does yield a
much higher frequency of  x in VH3H9/56R than in non-
tg. We account for this frequency in two ways. Most  s are
not editors leading to rapid deletion of the   locus and V x
is the only   editor. This means that the  1 and  2 popula-
tions are deleted and the  x population remains ( s do not
have  del elements, as far as we know, hence this rearrange-
ment is permanent). In addition, the simulation yields a
V 1 V 2: V x ratio of  3 in non-tg. Here we make the
reasonable assumption that  1 and  2 loci rearrange at the
same rate and that V 2 and V x rearrange at the same rate.
Because V 2 and V x rearrangements are mutually exclu-
sive, the above ratio should be 3. However, there is dis-
agreement on the actual ratio. A ratio close to 3 has been
observed (35), but we find the ratio is 20 (19).
There are several ways to explain the difference between
simulations and the data. The most interesting explanation
is antigen selection. The maintenance of B cells is thought
to require survival signals, one of which is thought to be
antigen. To explain the consistent appearance of B cells
with edited receptors like VH3H9/56R/ x or partially ed-
ited receptors like  /  double expressers, these receptors
must bind ubiquitous antigen(s). Such antigens are proba-
bly self and the edited populations found in the anti-DNA
tgs might owe their existence to self-reactivity. The anti-
DNA coreceptor in the 3H9/56R  /  B cell may promote
its survival and homing to the marginal zone, a process
thought to be driven by self-reactivity. The effective affin-
ity of these receptors with respect to selection may in this
case favor positive selection and clonal expansion, thereby
explaining the high frequency of this population.
The odd association of 3H9/56R/ x B cells with the
activation marker CD25 implies that the 3H9/56R/ x B
cells are antigen activated and that these B cells may have
reacted with antigen for extended periods before they rear-
ranged the  x editor. Although the pre- x DNA reactivity
in the presence of endogenous DNA might explain the ap-
pearance of an activation marker, it does not explain the
maintenance of this population after expression of the anti-
DNA editor,  x. However,  x-associated antibodies, in-
deed  x alone, are themselves anti-self. Both have been
shown to bind myelin basic protein (MBP; 32). In addi-
tion, a human mAb (a Waldenstrom’s macroglobulinemia
protein) that shares the same idiotype of mouse V x also
binds MBP (37). The lower than expected numbers of  x
B cells observed here and in  -deficient mice (reference 19
and Fig. 2) might be explained by deletion of self-reactive
 x B cells. Hence, editing might be a two-edged sword by
which expression of acidic editors that have evolved to pre-
vent DNA binding may also create reactivity to basic self-
proteins such as MBP. The association between anti-DNAs
and their editors may in turn edit the editors, but revision
of the B cell receptor, for example, by H chain replacement
or even H chain deletion might expose the autoreactivity
of the editor.
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